Filing Details

Accession Number:
0001225208-18-007833
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-17 17:56:44
Reporting Period:
2018-04-16
Accepted Time:
2018-04-17 17:56:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168014 M Mirian Weir Graddick Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth NJ 07033
Exe V-P, Hr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-16 24,000 $58.00 80,433 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
  2. Holdings include shares acquired in dividend reinvestment transactions.